Tamtam Try Tamtam free
Children's Hospital of The King's Daughters logo

Children's Hospital of The King's Daughters account plan

Pediatric health care services

At a glance

CHKD is Virginia's only freestanding, full-service pediatric hospital, in Norfolk, with $893,165 thousand of operating revenue in FY2025.

Children's Hospital of The King's Daughters (CHKD) is a nonprofit pediatric teaching hospital in Norfolk, Virginia, licensed for 266 beds and treating children from birth through age 21 across the Hampton Roads area. Its parent, Children's Health System, Inc. (CHS), also runs pediatric physician groups (Children's Medical Group and Children's Surgical Specialty Group), the Children's Health Foundation, an outpatient pharmacy and thrift stores. In FY2025 (year ended June 30, 2025) CHS reported total operating revenues of $893,165 thousand, up from $746,234 thousand, and an operating income of $51,261 thousand after an operating loss of $(35,310) thousand the year before. Revenue comes mainly from Medicaid, commercial insurers and TRICARE.

Business units

Strategic priorities

Restoring operating margin
The system achieved a 5.7 percent operating margin in FY2025, against a budgeted 6.1% and -4.7% the year before; operating income was $51,261 thousand.
Growing outpatient and surgical care
Net outpatient income is the largest revenue line at 47% ($461,093,000). Hospital outpatient clinic visits rose from 213,260 in 2023 to 232,787 in 2025, and surgeries from 13,358 to 14,279.
Expanding pediatric mental health
Children's Pavilion admissions rose from 460 in 2023 to 1,221 in 2025, and average daily census from 10.8 to 27.5.
Renovating facilities and systems
Renovations have temporarily reduced the hospital's beds in service to 193. Construction in progress of $15,346 thousand, with an estimated $7,189 thousand to complete, relates mainly to building renovations and software projects.
Community benefit and medical education
Community benefits at cost reached $130,665 thousand in FY2025, including medical education of $7,373 thousand; CHS trains residents through a partnership with Old Dominion University.

Investments and deals

Capital spending
Purchases of property, plant and equipment were $30,721 thousand in FY2025 (FY2024: $23,853 thousand), with remaining construction primarily building renovations and software projects.
Bond refinancing
On June 2, 2025 the Series 2025A refunding bond of $90,805 thousand, held by Truist Bank, replaced the Series 2015 bond and removed its letter of credit. Long-term debt totals $264,718 thousand of variable-rate bank-held bonds.
Investment portfolio
Investments and assets whose use is limited were $601,870 thousand at June 30, 2025, producing $70,495 thousand of net investment income in FY2025.

Challenges and risks

Medicaid exposure to federal policy
The One Big Beautiful Bill Act, enacted July 3, 2025, "may materially affect the organization's Medicaid reimbursement levels, patient coverage mix, and compliance obligations"; its impact cannot yet be estimated. Medicaid accounts for 24% of hospital receivables.
Rising cost base
Operating expenses reached $841,904 thousand in FY2025; salaries and benefits were $476,866 thousand and supplies rose to $142,631 thousand from $112,485 thousand.
Losses at physician subsidiaries
The for-profit physician groups lose money: CSSG had an operating loss of $(12,806) thousand and depends on a $12,352 thousand system subsidy, and CMG an operating loss of $(1,857) thousand.
Payor settlements and audits
Retroactive payor audits and settlement estimates move revenue materially: they decreased hospital patient service revenue by about $5,766 thousand in FY2025 after a $26,890 thousand uplift in FY2024.
Variable-rate debt and market risk
All long-term debt is variable-rate, and the portfolio includes hedge, real estate and private equity funds valued at NAV.

Where a supplier can help

Supply cost control
Supplies rose to $142,631 thousand in FY2025, a named cost challenge; group purchasing, inventory and supply chain tools can help protect the 5.7 percent operating margin.
Outpatient and surgical capacity
Tied to the outpatient growth priority: scheduling, patient access and ambulatory surgery solutions fit rising clinic visits and surgeries.
Behavioral health services
Children's Pavilion admissions nearly tripled since 2023; staffing, telehealth and care coordination offerings fit the mental health expansion priority.
Revenue cycle and payor compliance
Payor settlements and Medicaid policy changes are named challenges; revenue cycle, coding and compliance services help defend reimbursement.
Renovation and software projects
Ongoing building renovations and software projects, listed under capital spending, open room for construction, equipment and IT suppliers.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Children's Hospital of The King's Daughters?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Children's Hospital of The King's Daughters

What is Children's Hospital of The King's Daughters?

CHKD is Virginia's only freestanding, full-service pediatric hospital, a nonprofit teaching hospital in Norfolk licensed for 266 beds. It is part of Children's Health System, which also runs pediatric physician practices and a mental health hospital.

What is CHKD's revenue?

Children's Health System reported total operating revenues of $893,165 thousand for the fiscal year ended June 30, 2025, up from $746,234 thousand, with an operating income of $51,261 thousand.

Who pays for care at CHKD?

At June 30, 2025 hospital receivables came from Elevance Health (26%), Medicaid (24%), Tricare (16%), Sentara Health Plans (13%), Aetna, United Healthcare and Cigna.

Who governs CHKD?

It is governed by the Board of Directors of Children's Health System, Inc., chaired by Akhil Jain in FY2025.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)